Stay updated on PRT1419 in Hematologic Malignancies Clinical Trial
Sign up to get notified when there's something new on the PRT1419 in Hematologic Malignancies Clinical Trial page.

Latest updates to the PRT1419 in Hematologic Malignancies Clinical Trial page
- ChecktodayChange DetectedThe site revision label changed from v3.8.0 to v3.8.1.SummaryDifference0.1%

- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe footer now displays revision v3.8.0 instead of v3.7.2.SummaryDifference0.1%

- Check28 days agoChange DetectedA site-wide NIH notice about the transition from “Artificial Intelligence” to “Super Intelligence” appears, and the website revision identifier changes from v3.7.1 to v3.7.2. The study record content remains unchanged.SummaryDifference0.8%

- Check42 days agoChange DetectedThe footer revision label changes from v3.7.0 to v3.7.1.SummaryDifference0.1%

- Check63 days agoChange DetectedThe sponsor name is updated from Prelude Therapeutics to Prelude Therapeutics Incorporated, and the revision indicator updates to v3.7.0, replacing the prior sponsor entry and revision v3.6.6.SummaryDifference0.3%

- Check77 days agoChange DetectedThe page history now shows a new site revision, v3.6.6, replacing the previous v3.6.5. This is a system update to the page rather than a change to the study data or content.SummaryDifference0.1%

Stay in the know with updates to PRT1419 in Hematologic Malignancies Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PRT1419 in Hematologic Malignancies Clinical Trial page.